AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Efiglin-M 500mg/20mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Medopharm

Salt Composition

Metformin (500mg) + Teneligliptin (20mg)

Overview Efiglin-M 500mg/20mg Tablet ER

Metformin/glimepiride extended-release tablets (500mg/20mg) effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication mitigates the risk of severe diabetic complications, including renal impairment and vision loss, and may also lessen the likelihood of cardiovascular events. Efiglin-M ER may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy is achieved when combined with a balanced diet and regular physical activity. Dosage is personalized, considering individual health status, glycemic control, and concurrent medications. Consuming this medication with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit and should only be discontinued under medical supervision. This treatment helps regulate blood sugar and prevent future complications. Adherence to the prescribed diet and exercise regimen is crucial. Lifestyle choices significantly impact diabetes management. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal distress, and cephalalgia. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; understanding hypoglycemia recognition and management is essential. This medication is not universally appropriate. Prior to initiation, inform your physician of any history of hepatic, renal, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel before use. Potential drug interactions necessitate informing your doctor of all medications currently being taken. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Uses of Efiglin-M 500mg/20mg Tablet ER

Managing Type 2 Diabetes

Major Benefits of Efiglin-M 500mg/20mg Tablet ER:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Efiglin-M 500mg/20mg Extended-Release tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

Common Side effects of Efiglin-M 500mg/20mg Tablet ER:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Efiglin-M 500mg/20mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Efiglin-M 500mg/20mg Extended-Release tablets should be administered with food.

How Efiglin-M 500mg/20mg Tablet ER works:

Extended-release Efiglin-M tablets (500mg/20mg) contain a dual antidiabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Efiglin-M 500mg/20mg extended-release tablets with alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Efiglin-M 500mg/20mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Efiglin-M 500mg/20mg tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Efiglin-M 500mg/20mg Extended-Release Tablets on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Patients with kidney impairment should use Efiglin-M 500mg/20mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Efiglin-M 500mg/20mg Extended-Release tablets are contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely refrain from using Efiglin-M 500mg/20mg Extended-Release Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Efiglin-M 500mg/20mg Tablet ER :

Should you forget to take your Efiglin-M 500mg/20mg Extended-Release tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Never take more than one dose at a time.

Facts to Know About Efiglin-M 500mg/20mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Efiglin-M 500mg/20mg Tablet ER

Efiglin-M 500mg/20mg Tablet ER is safe when used as directed by your doctor. However, even with correct dosage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar). Hypoglycemia is more likely if you're also using insulin or sulfonylurea. Report any persistent issues to your doctor.
Efiglin-M 500mg/20mg Tablet ER rarely causes hypoglycemia by itself. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may indicate hypoglycemia, especially if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Nausea and vomiting are possible side effects of Efiglin-M 500mg/20mg Tablet ER. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) warrant immediate medical attention. Do not take other medications without your doctor's approval.
Efiglin-M 500mg/20mg Tablet ER is contraindicated in patients allergic to its components or excipients. Its use is also harmful for those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Efiglin-M 500mg/20mg Tablet ER can cause lactic acidosis (MALA—Metformin-associated lactic acidosis), a rare but serious side effect involving excess lactic acid in the blood. This risk is heightened in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. If you experience these, discontinue Efiglin-M 500mg/20mg Tablet ER and seek immediate medical attention.
Prolonged use of Efiglin-M 500mg/20mg Extended-Release Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may result in anemia, nerve damage (potentially causing tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and balance problems), necessitating medical attention. Your physician might recommend B12 level monitoring and supplementation if symptoms arise.
Store this medication in its original, tightly closed container, following the label's storage instructions. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Efiglin-M 500mg/20mg Tabl...
184
MRP 213
13% off